` 688046 (GemPharmatech Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

G
688046
vs
S
Shanghai Composite

Over the past 12 months, GemPharmatech Co Ltd has underperformed Shanghai Composite, delivering a return of +11% compared to the Shanghai Composite's +15% growth.

Stocks Performance
688046 vs Shanghai Composite

Loading
688046
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
688046 vs Shanghai Composite

Loading
688046
Shanghai Composite
Difference
www.alphaspread.com

Performance By Year
688046 vs Shanghai Composite

Loading
688046
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
GemPharmatech Co Ltd vs Peers

Shanghai Composite
688046
0KHE
TMO
DHR
LONN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

GemPharmatech Co Ltd
Glance View

GemPharmatech Co., Ltd. engages in research and development, manufacture, and sale of experimental mouse models. The company is headquartered in Nanjing, Jiangsu and currently employs 1,342 full-time employees. The company went IPO on 2022-04-25. The firm uses gene-editing and other technologies to produce mouse models. The firm also involves in the business of customized model breeding, drug efficacy analysis, and model customization. The Company’s products are mainly used to satisfy the experimental demands in the fields of gene function cognition, disease mechanisms analysis, drug target discovery, and other fundamental researches.

Intrinsic Value
20.03 CNY
Undervaluation 23%
Intrinsic Value
Price
G
Back to Top